Pereira S, Verhille J, Cailliau E, Bonniaud P, et al. Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab. Clin Exp Allergy 2023 Sep 13. doi: 10.1111/cea.14392.
PMID: 37705326